Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 301 entries
Sorted by: Best Match Show Resources per page
Spin-density matrix elements for γp→K*0Σ+ at Eγ=1.85-3.0 GeV with evidence for the κ(800) meson exchange.

Physical review letters

Hwang SH, Hicks K, Ahn JK, Nakano T, Ahn DS, Chang WC, Chen JY, Daté S, Ejiri H, Fujimura H, Fujiwara M, Fukui S, Gohn W, Hotta T, Imai K, Ishikawa T, Joo K, Kato Y, Kohri H, Kon Y, Lee HS, Maeda Y, Miyabe M, Mibe T, Morino Y, Muramatsu N, Nakatsugawa Y, Niiyama M, Noumi H, Oh Y, Ohashi Y, Ohta T, Oka M, Parker J, Rangacharyulu C, Ryu SY, Sawada T, Sugaya Y, Sumihama M, Tsunemi T, Uchida M, Ungaro M, Yosoi M.
PMID: 22463625
Phys Rev Lett. 2012 Mar 02;108(9):092001. doi: 10.1103/PhysRevLett.108.092001. Epub 2012 Feb 27.

The exclusive reaction γp→K(+)π(-)Σ(+) was measured for the first time using linearly polarized photons at beam energies from 1.85 to 2.96 GeV. Angular distributions in the rest frame of the K(+)π(-) system were fitted to extract spin-density matrix elements...

Cite
Hwang SH, Hicks K, Ahn JK, et al. Spin-density matrix elements for γp→K*0Σ+ at Eγ=1.85-3.0 GeV with evidence for the κ(800) meson exchange. Phys Rev Lett. 2012;108(9):092001doi: 10.1103/PhysRevLett.108.092001.
Hwang, S. H., Hicks, K., Ahn, J. K., Nakano, T., Ahn, D. S., Chang, W. C., Chen, J. Y., Daté, S., Ejiri, H., Fujimura, H., Fujiwara, M., Fukui, S., Gohn, W., Hotta, T., Imai, K., Ishikawa, T., Joo, K., Kato, Y., Kohri, H., Kon, Y., Lee, H. S., Maeda, Y., Miyabe, M., Mibe, T., Morino, Y., Muramatsu, N., Nakatsugawa, Y., Niiyama, M., Noumi, H., Oh, Y., Ohashi, Y., Ohta, T., Oka, M., Parker, J., Rangacharyulu, C., Ryu, S. Y., Sawada, T., Sugaya, Y., Sumihama, M., Tsunemi, T., Uchida, M., Ungaro, M., Yosoi, M. (2012). Spin-density matrix elements for γp→K*0Σ+ at Eγ=1.85-3.0 GeV with evidence for the κ(800) meson exchange. Physical review letters, 108(9), 092001. https://doi.org/10.1103/PhysRevLett.108.092001
Hwang, S H, et al. "Spin-density matrix elements for γp→K*0Σ+ at Eγ=1.85-3.0 GeV with evidence for the κ(800) meson exchange." Physical review letters vol. 108,9 (2012): 092001. doi: https://doi.org/10.1103/PhysRevLett.108.092001
Hwang SH, Hicks K, Ahn JK, Nakano T, Ahn DS, Chang WC, Chen JY, Daté S, Ejiri H, Fujimura H, Fujiwara M, Fukui S, Gohn W, Hotta T, Imai K, Ishikawa T, Joo K, Kato Y, Kohri H, Kon Y, Lee HS, Maeda Y, Miyabe M, Mibe T, Morino Y, Muramatsu N, Nakatsugawa Y, Niiyama M, Noumi H, Oh Y, Ohashi Y, Ohta T, Oka M, Parker J, Rangacharyulu C, Ryu SY, Sawada T, Sugaya Y, Sumihama M, Tsunemi T, Uchida M, Ungaro M, Yosoi M. Spin-density matrix elements for γp→K*0Σ+ at Eγ=1.85-3.0 GeV with evidence for the κ(800) meson exchange. Phys Rev Lett. 2012 Mar 02;108(9):092001. doi: 10.1103/PhysRevLett.108.092001. Epub 2012 Feb 27. PMID: 22463625.
Copy Download .nbib Format: NLM
Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe.

Journal of market access & health policy

Medic G, Korchagina D, Young KE, Toumi M, Postma MJ, Wille M, Hemels M.
PMID: 28473888
J Mark Access Health Policy. 2017 Apr 10;5(1):1299665. doi: 10.1080/20016689.2017.1299665. eCollection 2017.

No abstract available.

Cite
Medic G, Korchagina D, Young KE, et al. Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe. J Mark Access Health Policy. 2017;5(1):1299665doi: 10.1080/20016689.2017.1299665.
Medic, G., Korchagina, D., Young, K. E., Toumi, M., Postma, M. J., Wille, M., & Hemels, M. (2017). Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe. Journal of market access & health policy, 5(1), 1299665. https://doi.org/10.1080/20016689.2017.1299665
Medic, Goran, et al. "Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe." Journal of market access & health policy vol. 5,1 (2017): 1299665. doi: https://doi.org/10.1080/20016689.2017.1299665
Medic G, Korchagina D, Young KE, Toumi M, Postma MJ, Wille M, Hemels M. Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe. J Mark Access Health Policy. 2017 Apr 10;5(1):1299665. doi: 10.1080/20016689.2017.1299665. eCollection 2017. PMID: 28473888; PMCID: PMC5405566.
Copy Download .nbib Format: NLM
Filling the gap in CNS drug development: evaluation of the role of drug repurposing.

Journal of market access & health policy

Caban A, Pisarczyk K, Kopacz K, Kapuśniak A, Toumi M, Rémuzat C, Kornfeld A.
PMID: 28473889
J Mark Access Health Policy. 2017 Apr 10;5(1):1299833. doi: 10.1080/20016689.2017.1299833. eCollection 2017.

No abstract available.

Cite
Caban A, Pisarczyk K, Kopacz K, et al. Filling the gap in CNS drug development: evaluation of the role of drug repurposing. J Mark Access Health Policy. 2017;5(1):1299833doi: 10.1080/20016689.2017.1299833.
Caban, A., Pisarczyk, K., Kopacz, K., Kapuśniak, A., Toumi, M., Rémuzat, C., & Kornfeld, A. (2017). Filling the gap in CNS drug development: evaluation of the role of drug repurposing. Journal of market access & health policy, 5(1), 1299833. https://doi.org/10.1080/20016689.2017.1299833
Caban, A, et al. "Filling the gap in CNS drug development: evaluation of the role of drug repurposing." Journal of market access & health policy vol. 5,1 (2017): 1299833. doi: https://doi.org/10.1080/20016689.2017.1299833
Caban A, Pisarczyk K, Kopacz K, Kapuśniak A, Toumi M, Rémuzat C, Kornfeld A. Filling the gap in CNS drug development: evaluation of the role of drug repurposing. J Mark Access Health Policy. 2017 Apr 10;5(1):1299833. doi: 10.1080/20016689.2017.1299833. eCollection 2017. PMID: 28473889; PMCID: PMC5405562.
Copy Download .nbib Format: NLM
"Saddling people with loans will put off mature students".

Nursing times

Koumi S.
PMID: 27145670
Nurs Times. 2016 Mar 16-22;112(11):11.

No abstract available.

Cite
Koumi S. "Saddling people with loans will put off mature students". Nurs Times. 2016;112(11):11
Koumi, S. (2016). "Saddling people with loans will put off mature students". Nursing times, 112(11), 11.
Koumi, Sophia. ""Saddling people with loans will put off mature students"." Nursing times vol. 112,11 (2016): 11.
Koumi S. "Saddling people with loans will put off mature students". Nurs Times. 2016 Mar 16-22;112(11):11. PMID: 27145670.
Copy Download .nbib Format: NLM
Key drivers for market penetration of biosimilars in Europe.

Journal of market access & health policy

Rémuzat C, Dorey J, Cristeau O, Ionescu D, Radière G, Toumi M.
PMID: 28265349
J Mark Access Health Policy. 2017 Jan 30;5(1):1272308. doi: 10.1080/20016689.2016.1272308. eCollection 2017.

No abstract available.

Cite
Rémuzat C, Dorey J, Cristeau O, et al. Key drivers for market penetration of biosimilars in Europe. J Mark Access Health Policy. 2017;5(1):1272308doi: 10.1080/20016689.2016.1272308.
Rémuzat, C., Dorey, J., Cristeau, O., Ionescu, D., Radière, G., & Toumi, M. (2017). Key drivers for market penetration of biosimilars in Europe. Journal of market access & health policy, 5(1), 1272308. https://doi.org/10.1080/20016689.2016.1272308
Rémuzat, Cécile, et al. "Key drivers for market penetration of biosimilars in Europe." Journal of market access & health policy vol. 5,1 (2017): 1272308. doi: https://doi.org/10.1080/20016689.2016.1272308
Rémuzat C, Dorey J, Cristeau O, Ionescu D, Radière G, Toumi M. Key drivers for market penetration of biosimilars in Europe. J Mark Access Health Policy. 2017 Jan 30;5(1):1272308. doi: 10.1080/20016689.2016.1272308. eCollection 2017. PMID: 28265349; PMCID: PMC5328350.
Copy Download .nbib Format: NLM
An Overview of Infant Mortality Trends in Qatar from 2004 to 2014.

Cureus

Al-Thani M, Al-Thani AA, Toumi A, Khalifa SE, Akram H.
PMID: 29152426
Cureus. 2017 Sep 09;9(9):e1669. doi: 10.7759/cureus.1669.

Background Infant mortality is an important health indicator that estimates population well-being. Infant mortality has declined globally but is still a major public health challenge. This article provides the characteristics, causes, burden, and trends of infant mortality in Qatar....

Cite
Al-Thani M, Al-Thani AA, Toumi A, et al. An Overview of Infant Mortality Trends in Qatar from 2004 to 2014. Cureus. 2017;9(9):e1669doi: 10.7759/cureus.1669.
Al-Thani, M., Al-Thani, A. A., Toumi, A., Khalifa, S. E., & Akram, H. (2017). An Overview of Infant Mortality Trends in Qatar from 2004 to 2014. Cureus, 9(9), e1669. https://doi.org/10.7759/cureus.1669
Al-Thani, Mohammed, et al. "An Overview of Infant Mortality Trends in Qatar from 2004 to 2014." Cureus vol. 9,9 (2017): e1669. doi: https://doi.org/10.7759/cureus.1669
Al-Thani M, Al-Thani AA, Toumi A, Khalifa SE, Akram H. An Overview of Infant Mortality Trends in Qatar from 2004 to 2014. Cureus. 2017 Sep 09;9(9):e1669. doi: 10.7759/cureus.1669. PMID: 29152426; PMCID: PMC5679762.
Copy Download .nbib Format: NLM
A review of the value of innovation in inhalers for COPD and asthma.

Journal of market access & health policy

Virchow JC, Akdis CA, Darba J, Dekhuijzen R, Hartl S, Kobelt G, Roger A, Simoens S, Toumi M, Woodhouse B, Plich A, Torvinen S.
PMID: 27123170
J Mark Access Health Policy. 2015 Sep 16;3. doi: 10.3402/jmahp.v3.28760. eCollection 2015.

BACKGROUND: Appropriate use of inhaled therapies for asthma and chronic obstructive pulmonary disease (COPD) is critical to ensuring good patient outcomes, efficient use of healthcare resources and limiting the effects of high-morbidity. The appropriate choice of inhaler and active...

Cite
Virchow JC, Akdis CA, Darba J, et al. A review of the value of innovation in inhalers for COPD and asthma. J Mark Access Health Policy. 2015;3doi: 10.3402/jmahp.v3.28760.
Virchow, J. C., Akdis, C. A., Darba, J., Dekhuijzen, R., Hartl, S., Kobelt, G., Roger, A., Simoens, S., Toumi, M., Woodhouse, B., Plich, A., & Torvinen, S. (2015). A review of the value of innovation in inhalers for COPD and asthma. Journal of market access & health policy, 3. https://doi.org/10.3402/jmahp.v3.28760
Virchow, Johann Christian, et al. "A review of the value of innovation in inhalers for COPD and asthma." Journal of market access & health policy vol. 3 (2015). doi: https://doi.org/10.3402/jmahp.v3.28760
Virchow JC, Akdis CA, Darba J, Dekhuijzen R, Hartl S, Kobelt G, Roger A, Simoens S, Toumi M, Woodhouse B, Plich A, Torvinen S. A review of the value of innovation in inhalers for COPD and asthma. J Mark Access Health Policy. 2015 Sep 16;3. doi: 10.3402/jmahp.v3.28760. eCollection 2015. PMID: 27123170; PMCID: PMC4802681.
Copy Download .nbib Format: NLM
National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.

Journal of market access & health policy

Ricciardi W, Toumi M.
PMID: 27123172
J Mark Access Health Policy. 2015 Sep 14;3. doi: 10.3402/jmahp.v3.29276. eCollection 2015.

No abstract available.

Cite
Ricciardi W, Toumi M. National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning. J Mark Access Health Policy. 2015;3doi: 10.3402/jmahp.v3.29276.
Ricciardi, W., & Toumi, M. (2015). National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning. Journal of market access & health policy, 3. https://doi.org/10.3402/jmahp.v3.29276
Ricciardi, Walter, and Toumi, Mondher. "National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning." Journal of market access & health policy vol. 3 (2015). doi: https://doi.org/10.3402/jmahp.v3.29276
Ricciardi W, Toumi M. National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning. J Mark Access Health Policy. 2015 Sep 14;3. doi: 10.3402/jmahp.v3.29276. eCollection 2015. PMID: 27123172; PMCID: PMC4802683.
Copy Download .nbib Format: NLM
Infrared study of matrix-isolated ethyl cyanide: simulation of the photochemistry in the atmosphere of Titan.

Physical chemistry chemical physics : PCCP

Toumi A, Piétri N, Couturier-Tamburelli I.
PMID: 26507585
Phys Chem Chem Phys. 2015 Nov 11;17(45):30352-63. doi: 10.1039/c5cp03616j.

Low-temperature Ar matrix isolation has been carried out to investigate the infrared spectrum of ethyl cyanide (CH3CH2CN), a molecule present in the atmosphere of Titan. The λ > 120 nm and λ > 230 nm photolysis reactions of ethyl...

Cite
Toumi A, Piétri N, Couturier-Tamburelli I. Infrared study of matrix-isolated ethyl cyanide: simulation of the photochemistry in the atmosphere of Titan. Phys Chem Chem Phys. 2015;17(45):30352-63doi: 10.1039/c5cp03616j.
Toumi, A., Piétri, N., & Couturier-Tamburelli, I. (2015). Infrared study of matrix-isolated ethyl cyanide: simulation of the photochemistry in the atmosphere of Titan. Physical chemistry chemical physics : PCCP, 17(45), 30352-63. https://doi.org/10.1039/c5cp03616j
Toumi, A, et al. "Infrared study of matrix-isolated ethyl cyanide: simulation of the photochemistry in the atmosphere of Titan." Physical chemistry chemical physics : PCCP vol. 17,45 (2015): 30352-63. doi: https://doi.org/10.1039/c5cp03616j
Toumi A, Piétri N, Couturier-Tamburelli I. Infrared study of matrix-isolated ethyl cyanide: simulation of the photochemistry in the atmosphere of Titan. Phys Chem Chem Phys. 2015 Nov 11;17(45):30352-63. doi: 10.1039/c5cp03616j. PMID: 26507585.
Copy Download .nbib Format: NLM
Conflict Of Interest in HTA Recommendations and Case Law In France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Frybourg S, Kornfeld A, Brunet J, Toumi M.
PMID: 27201233
Value Health. 2014 Nov;17(7):A450. doi: 10.1016/j.jval.2014.08.1214. Epub 2014 Oct 26.

No abstract available.

Cite
Frybourg S, Kornfeld A, Brunet J, et al. Conflict Of Interest in HTA Recommendations and Case Law In France. Value Health. 2014;17(7):A450doi: 10.1016/j.jval.2014.08.1214.
Frybourg, S., Kornfeld, A., Brunet, J., & Toumi, M. (2014). Conflict Of Interest in HTA Recommendations and Case Law In France. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A450. https://doi.org/10.1016/j.jval.2014.08.1214
Frybourg, S, et al. "Conflict Of Interest in HTA Recommendations and Case Law In France." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A450. doi: https://doi.org/10.1016/j.jval.2014.08.1214
Frybourg S, Kornfeld A, Brunet J, Toumi M. Conflict Of Interest in HTA Recommendations and Case Law In France. Value Health. 2014 Nov;17(7):A450. doi: 10.1016/j.jval.2014.08.1214. Epub 2014 Oct 26. PMID: 27201233.
Copy Download .nbib Format: NLM
Future Impact of Dementia on the Caregiver in China.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Clay E, Yan J, Aballéa S, Toumi M.
PMID: 27202832
Value Health. 2014 Nov;17(7):A769. doi: 10.1016/j.jval.2014.08.305. Epub 2014 Oct 26.

No abstract available.

Cite
Clay E, Yan J, Aballéa S, et al. Future Impact of Dementia on the Caregiver in China. Value Health. 2014;17(7):A769doi: 10.1016/j.jval.2014.08.305.
Clay, E., Yan, J., Aballéa, S., & Toumi, M. (2014). Future Impact of Dementia on the Caregiver in China. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A769. https://doi.org/10.1016/j.jval.2014.08.305
Clay, E, et al. "Future Impact of Dementia on the Caregiver in China." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A769. doi: https://doi.org/10.1016/j.jval.2014.08.305
Clay E, Yan J, Aballéa S, Toumi M. Future Impact of Dementia on the Caregiver in China. Value Health. 2014 Nov;17(7):A769. doi: 10.1016/j.jval.2014.08.305. Epub 2014 Oct 26. PMID: 27202832.
Copy Download .nbib Format: NLM
Health Technology Assessments In Oncology: Crizotinib Case Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Thivolet M, Kornfeld A, Toumi M.
PMID: 27202404
Value Health. 2014 Nov;17(7):A661. doi: 10.1016/j.jval.2014.08.2424. Epub 2014 Oct 26.

No abstract available.

Cite
Thivolet M, Kornfeld A, Toumi M. Health Technology Assessments In Oncology: Crizotinib Case Study. Value Health. 2014;17(7):A661doi: 10.1016/j.jval.2014.08.2424.
Thivolet, M., Kornfeld, A., & Toumi, M. (2014). Health Technology Assessments In Oncology: Crizotinib Case Study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A661. https://doi.org/10.1016/j.jval.2014.08.2424
Thivolet, M, et al. "Health Technology Assessments In Oncology: Crizotinib Case Study." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A661. doi: https://doi.org/10.1016/j.jval.2014.08.2424
Thivolet M, Kornfeld A, Toumi M. Health Technology Assessments In Oncology: Crizotinib Case Study. Value Health. 2014 Nov;17(7):A661. doi: 10.1016/j.jval.2014.08.2424. Epub 2014 Oct 26. PMID: 27202404.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 301 entries